Dennis Juarez

机构：University of California, Irvine, The Ohio State University Wexner Medical Center, Irvine University · ORCID：0000-0002-2458-8879

发表论文 80 篇 · 总被引 295 次 · h-index 5

代表论文

• A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy (2024 · Blood Neoplasia · 被引 9)
• Pitavastatin counteracts venetoclax resistance mechanisms including TP53 mutation in acute myeloid leukemia (2026 · Blood Neoplasia)
• Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer (2025 · bioRxiv (Cold Spring Harbor Laboratory))
• Pitavastatin Potentiates Mitochondrial Dysfunction and Venetoclax Cytotoxicity in Acute Myeloid Leukemia Cells (2024 · Blood)
• Abstract C052: Repurposing Statins to Target Gemcitabine Resistance in Pancreatic Cancer (2024 · Cancer Research)
• Abstract A056: Targeting the mevalonate biosynthesis pathway in gemcitabine resistant pancreatic cancer (2024 · Cancer Research)